Cancer Knowledge Network: What is the International Consensus on Screening for Heart Problems in Childhood Cancer Survivors?

October 19, 2017

RESEARCH:  The Lancet Oncology:  Recommendations for cardiomyopathy surveillance for survivors of childhood cancer: a report from the International Late Effects of Childhood Cancer Guideline Harmonization Group.  Experts in late effects screening from the United States and Europe completed a combined review of current guidelines that direct screening for heart problems in survivors of childhood cancer.  Participants in […]

Business Wire: Genomic Vision – Report of the LSR R&D Day

October 18, 2017

Genomic Vision (Paris:GV) (Euronext: FR0011799907 – GV), a company specialized in the development of diagnostic tests for the early detection of cancers and genetic diseases, today reports of its second R&D Day which took place on October 16 in Paris and was attended by clients, investors, analysts, and journalists. This second edition was aimed at […]

Cancer Knowledge Network: Chemotherapy Exposure and EKG Changes: What Do They Mean?

October 5, 2017

Pediatric Blood and Cancer: Electrophysiological effects of anthracyclines in adult survivors of pediatric malignancy. Researchers at Johns Hopkins Hospital conducted a retrospective chart review of 147 survivors of childhood cancer that were now over the age of 18. The goal of the study was to evaluate the correlation between abnormalities in electrocardiographic changes and cardiac […]

Medical Xpress: Anti-RAS antibodies show poor reliability in recognizing RAS proteins

October 5, 2017

Researchers from the Greehey Children’s Cancer Research Institute at UT Health San Antonio co-authored a paper published Sept. 26 in Science Signaling that looks at the reliability of a common research tool to study RAS cancer mutations. RAS mutations are implicated in several cancers, including lung, colorectal, and pancreatic ductal carcinoma. The three RAS genes are the […]

CPRIT TV: Dr. Peter Houghton on Childhood Cancer Research

October 4, 2017

“Dr. Peter Houghton, Director of the Greehey Children’s Cancer Research Institute at The University of Texas Health Science Center at San Antonio, discusses CPRIT and childhood cancer research.”     Houghton Lab

UT Health SA Newsroom: Greehey scientists contribute to study of RAS-sensing antibodies

September 28, 2017

Researchers from the Greehey Children’s Cancer Research Institute at UT Health San Antonio are co-authors on a paper published Sept. 26 in Science Signaling, a high-impact journal that is part of the Science family of journals. RAS mutations are implicated in several cancers, including lung, colorectal and pancreatic ductal carcinoma. The three RAS genes are the most frequently mutated […]

TEXAS PUBLIC RADIO: About 1,800 Children Die Of Cancer Every Year In The U.S.

September 25, 2017

More than 15,000 children and adolescents up to 19 years old will receive a cancer diagnosis this year, according to the National Cancer Institute. After accidents, cancer is the second leading cause of death in children ages 1 to 14. Conditions most commonly affecting children include leukemia, lymphoma, and tumors affecting the bones or neural systems.